2151 - 2160 of 6258 Results
Title
Year
-
OPENTitle: Deep brain stimulation for levodopa-refractory benign tremulous parkinsonismJournal Name: Neurologia i Neurochirurgia PolskaPublisher: VM Media SP. zo.o VM Group SKVol: 50Issue #: 5Start Page: 383End Page: 386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pjnns.2016.05.008Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0028384316300573Citation Count: 1
-
OPENTitle: Is PARKIN parkinsonism a cancer predisposition syndrome?Journal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 1Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000031Best OA location URL: https://ng.neurology.org/content/nng/1/4/e31.full.pdfCitation Count: 4
-
OPENTitle: Pantothenate kinase‐associated neurodegeneration is not a synucleinopathyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 39Issue #: 2Start Page: 121End Page: 131Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.1111/j.1365-2990.2012.01269.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2990.2012.01269.xCitation Count: 52
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats2011OPENTitle: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 6Start Page: 861End Page: 868Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3133531Citation Count: 71
- α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats2013OPENTitle: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 71Issue #:Start Page: 191End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3685407Citation Count: 44
- Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats2010OPENTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3820002Citation Count: 20
- Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats2009OPENTitle: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 944End Page: 955Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3820009Citation Count: 46
- Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats2009OPENTitle: Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 956End Page: 969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.019Best OA location URL: http://doi.org/10.1016/j.neuropharm.2009.01.019Citation Count: 53
-
OPENTitle: Impaired perception of biological motion in Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 30Issue #: 6Start Page: 720End Page: 730Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000276Best OA location URL: https://doi.org/10.1037/neu0000276Citation Count: 49
-
OPENTitle: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working MemoryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 9Start Page: 2224End Page: 2231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2016.14Best OA location URL: https://www.nature.com/articles/npp201614.pdfCitation Count: 27